MedTrace Logo

Effects of Gait Training With and Without PNF on Balance ,Gait and Activities of Daily Living in Parkinson's Patients

NCT06789133 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-01-23

No results posted yet for this study

Summary

Proprioceptive Neuromuscular Facilitation (PNF) and gait training exercises are specifically used to treat balance, gait and functional activities in Parkinson s patients. PNF has been compared with gait training and balance training in other conditions like stroke and multiple sclerosis but limited literatures are present in which PNF has been compared with gait training in Parkinson patients.

Conditions

  • Parkinson Disease (PD)
  • Proprioceptive Neuromuscular Facilitation

Interventions

OTHER

PNF exercises and Body weight supported treadmill gait training

PNF Exercises: .Proprioceptive neuromuscular facilitation exercises include D1 Flexion and D1 Extension of lower limb ,D2 flexion D2 extension of lower limb .rhythmic initiation ,hold relax ,pelvic pattern and contract relax technique . subjects will perform each exercise for 30sec with resting interval of 30 to 60 seconds Will be provided after completion of each exercise. 3 sessions will be held per week, For 8 weeks Gait training: Body weight supported treadmill gait training for 20 minutes 3 sessions per week. In total all PNF exercises with gait training will be held for 40-45 minutes.

OTHER

Body weight supported treadmill gait training and Routine physical therapy

Body Weight Supported Treadmill Training (BWSTT): This will include body weight supported treadmill gait training. 10 % BWSTT or 20% BWSTT. The session will of 20 minutes .3 sessions will be Held per week. Routine physical therapy: Stretching and strengthening of lower extremities In total all BWSTT along with routine physical therapy protocol will be held for 40-45minutes .3 sessions will be held per week.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Arnab Altaf, MSDPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-10-01
Completion
2024-11-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06789133 on ClinicalTrials.gov